0001213900-24-041832.txt : 20240510
0001213900-24-041832.hdr.sgml : 20240510
20240510172009
ACCESSION NUMBER: 0001213900-24-041832
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240510
DATE AS OF CHANGE: 20240510
EFFECTIVENESS DATE: 20240510
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAINZ BIOMED N.V.
CENTRAL INDEX KEY: 0001874252
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-486514
FILM NUMBER: 24936058
BUSINESS ADDRESS:
STREET 1: ROBERT KOCH STRASSE 50
CITY: MAINZ
STATE: 2M
ZIP: 55129
BUSINESS PHONE: 49 6131 5542860
MAIL ADDRESS:
STREET 1: ROBERT KOCH STRASSE 50
CITY: MAINZ
STATE: 2M
ZIP: 55129
FORMER COMPANY:
FORMER CONFORMED NAME: Mainz Biomed B.V.
DATE OF NAME CHANGE: 20210721
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001874252
MAINZ BIOMED N.V.
ROBERT KOCH STRASSE 50
MAINZ
2M
GERMANY
55129
+49-6131-55428-60
NETHERLANDS
None
Mainz Biomed B.V.
Corporation
true
2021
William
Caragol
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Executive Officer
Guido
Baechler
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Executive Officer
Director
Moritz
Eidens
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Executive Officer
Director
Heiner
Dreismann
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Director
Nicole
Holden
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Director
Hans
Hekland
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Director
Alberto
Libanori
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Director
Phillip
Freese
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Executive Officer
Darin
Leigh
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Executive Officer
Gregory
Tibbits
Robert Koch Strasse 50
c/o Mainz Biomed N.V.
Mainz
2M
GERMANY
55129
Director
Biotechnology
Decline to Disclose
- 06b
true
0001213900-23-056204
2023-06-28
false
true
true
true
true
false
0
50000000
14300000
35700000
Offering of $3,300,000 of ordinary shares under pre-paid advance agreement via promissory note convertible up to 4,166,667 shares at conversion price of $1.20 (subject to a reset date and floor) until four-month anniversary of the promissory note.
false
1
0
0
0
true
false
MAINZ BIOMED N.V.
/s/ William J. Caragol
William J Caragol
Chief Financial Officer
2024-05-10